If you or someone you know may be experiencing a mental health crisis, contact the 988 Suicide & Crisis Lifeline by dialing or texting “988.”
The American healthcare system is frequently characterized by administrative friction, administrative backlogs, and bureaucratic red tape that often prevents vulnerable patients from receiving timely medical interventions. For decades-long smoker Kenney Blewett of Kyle, Texas, this systemic friction proved to be an insurmountable hurdle during the final, agonizing days of his life. Diagnosed with chronic obstructive pulmonary disease (COPD) more than a decade ago, Blewett experienced a severe escalation in his respiratory health in the early months of the year. Simple daily activities, such as taking out the household trash, left him completely winded. He experienced terrifying flare-ups that his wife, Cindy Blewett, described as "the scariest thing in the world." These episodes, though typically lasting only a few minutes, grew increasingly frequent, leading to a drastic decline in his quality of life, profound physical isolation, and a 45-pound weight loss.
When a doctor reportedly told him, "That sounds like cancer," the psychological weight compounded his physical suffering. On June 2, seeking desperately to alleviate his terrifying breathing issues, Blewett visited his pulmonologist, Dr. Rajesh Shetty of LungDocs, who promptly wrote a prescription for a new nebulizer medication designed to manage his advanced COPD. However, what should have been a straightforward path to relief transformed into a labyrinth of administrative delays, insurance confusion, and pharmacy bottlenecks. Two days after the appointment, Blewett received an automated email from a local Walgreens pharmacy explaining that, due to an unresolved insurance issue, the fulfillment of his critical medication was delayed. Five days later, on the evening of June 7, following a particularly severe flare-up, Kenney Blewett died by suicide at the age of 82, having never received the medication that might have offered him physical relief and hope.
A Chronology of Bureaucratic Breakdown
The sequence of events leading up to June 7 highlights the fragile and often opaque nature of modern pharmaceutical fulfillment and insurance processing. On Tuesday, June 2, Blewett attended his pulmonologist appointment where two separate prescriptions were generated. One was routed through traditional channels to the local Walgreens pharmacy, while a second medication was ordered directly from the drug manufacturer.
By June 4, the promised text or email notification that the prescription was ready for pickup had not arrived. Instead, Blewett received an electronic notification from Walgreens indicating a delay tied to an insurance issue. Over the next several days, Cindy Blewett fielded communications and attempted to untangle a confusing web of liability between the pharmacy, federal healthcare programs, and private insurers.
According to statements gathered retrospectively by Cindy, the pharmacy attempted to process the nebulizer medication through Medicare Part B under its durable medical equipment benefit, rather than the more common Part D prescription drug plan. However, the claim stalled because it allegedly lacked a specific diagnostic code that the physician’s office was required to provide. While a Walgreens district supervisor later maintained that the pharmacy faxed a request for the diagnostic code to Dr. Shetty’s office on the afternoon of June 2, representatives from the pulmonologist’s office reportedly stated they had no record of receiving such a transmission.
On Sunday afternoon, June 7, Kenney experienced another harrowing COPD flare-up. Later that evening, while Cindy sat on their back porch, she heard a sharp noise she initially mistook for a fallen picture frame. It was a gunshot. Kenney had taken his own life in their bedroom. Weeks later, the second medication ordered directly from the manufacturer finally arrived at their home—too late to make a difference.
The Broader Crisis of Prior Authorization and Insurance Red Tape
The tragic narrative of the Blewett family unfolds against a backdrop of widespread dissatisfaction with the United States healthcare apparatus. Insurance delays, denials, and prior authorization requirements have become notorious systemic features. According to a January KFF Health Tracking Poll, nearly 7 in 10 American adults view insurance preapproval hurdles as a major problem when attempting to access necessary medical care.
Prior authorization—a mechanism requiring physicians to obtain pre-approval from an insurance provider before a treatment or medication is covered—was originally designed to curb unnecessary spending and prevent inappropriate care. In practice, however, critics argue it has metastasized into a pervasive barrier that delays essential medical interventions, increases administrative overhead for clinical staff, and endangers patient health.
In June 2025, exactly six months after the fatal shooting of UnitedHealthcare’s CEO in New York cast a harsh national spotlight on insurance industry practices, the administration announced a highly publicized voluntary pledge. Dozens of major health insurers signed the agreement, promising to streamline prior authorization processes and remove unnecessary barriers to doctor-recommended care. However, the pledge carried no legal enforcement mechanisms, financial penalties, or regulatory mandates for non-compliance. A follow-up report published by KFF Health News revealed that several signatory insurers ultimately failed to implement all promised reforms as originally outlined.
In the absence of comprehensive federal intervention, lawmakers across most states, including Texas, have increasingly attempted to regulate the insurance industry locally. Yet, structural limitations remain a major obstacle. Most health insurance arrangements—including traditional Medicare policies and employer-sponsored health plans, which collectively cover more than half of all Americans—fall outside the jurisdiction of state-level regulations, leaving patients to navigate a fractured patchwork of rules.
Navigating a Labyrinth: Medicare Complexity and AI Integration
For beneficiaries, understanding which administrative body governs a specific treatment can be overwhelmingly complex. Mike Hess, senior director of advocacy and regulatory affairs at the nonprofit COPD Foundation, noted that the Medicare system has evolved to be exceedingly convoluted over the years. The distinction between Medicare Part B (which covers durable medical equipment and certain inhalation drugs administered via nebulizers) and Part D (which covers traditional retail prescription drugs) frequently confuses not only patients and their caregivers, but also medical office staff and retail pharmacy employees.
Compounding this confusion is the rapid integration of artificial intelligence into healthcare administration. Insurers and federal agencies are increasingly deploying AI tools to process claims, evaluate medical necessity, and manage prior authorizations. While proponents argue that automation roots out waste and accelerates processing times, healthcare providers and patient advocates warn that algorithmic decision-making frequently introduces opaque errors, inappropriate denials, and automated rejections that are difficult to appeal.
Traditional Medicare historically utilized prior authorization sparingly compared to private Medicare Advantage plans. However, in January, federal health authorities launched a pilot program across six states—including Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington—to test the deployment of artificial intelligence in preapproving select healthcare services within Original Medicare. Although this pilot program has not yet formally targeted COPD medications, healthcare experts anticipate that the scope of algorithmic oversight will expand to encompass a broader array of treatments and jurisdictions, potentially intensifying administrative friction for vulnerable populations.
Systemic Implications and Patient Advocacy
Industry analysts argue that the administrative burdens currently plaguing the healthcare system demand urgent structural reform. Matt Toresco, CEO of Archő, a patient advocacy and consulting firm, emphasized the severity of the crisis, stating that the current environment has "gotten completely out of hand" and that patients require significantly more institutional support to overcome arbitrary insurance hurdles.
For Cindy Blewett, the bureaucratic maze left behind deep, unresolved grief and unanswered questions. Despite exhaustive inquiries directed at Medicare, private plan administrators, pharmacy management, and clinical offices, she remains uncertain about where accountability lies for the fatal delay of her husband’s medication.
"Short of getting attorneys involved," Cindy reflected, "I’m not sure how to find out what really happened." As she preserves the memory of her late husband—with whom she celebrated their 60th wedding anniversary earlier in the year—she is left to ponder a devastating hypothetical: whether timely access to a simple prescription could have altered the trajectory of Kenney’s final days, prevented his severe respiratory distress, and preserved a life shared over six decades.
